The global urodynamic equipment and consumables market size was valued at USD 303.7 million in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2030. Increasing prevalence of bladder and renal problems, increase in prevalence of lower urinary tract symptoms (LUTS), and urological disorders are the factors driving urodynamic equipment and consumables market.
Worldwide industry growth is driven by the increasing prevalence of LUTS and urological disorders. According to a 2023 study by the National Institute of Health, approximately 423 million people worldwide experience urinary incontinence. As the global population ages, the incidence of these conditions is expected to rise, necessitating the adoption of effective diagnostic tools and treatment options.
The market is also driven by the focus on developing user-friendly and cost-effective solutions, which is expected to further stimulate growth. Healthcare facilities seek to optimize their operations while providing high-quality care, and the adoption of advanced devices, including uroflowmetry equipment, cystometers, and ambulatory urodynamic systems, has improved diagnostic capabilities. As healthcare providers become more informed about the benefits of urodynamic testing, the adoption of these technologies is likely to increase, contributing to the overall expansion of the market.
The promotion of early diagnosis and treatment is crucial for the urodynamic equipment market. Governments and health organizations are implementing awareness and education initiatives to promote LUTS and urinary incontinence, thereby increasing adoption of diagnostic tools and treatment options. This strategic effort is expected to drive market growth and enhance patient care.
Uroflowmetry equipment accounted for the largest market share of 29.3% in 2023. The rising prevalence of diseases such as diabetes and hypertension is driving the need for enhanced diagnosis and treatment of related urological complications, including bladder dysfunction. Advances in uroflowmetry equipment, such as digital uroflowmeters, offer accuracy and ease of use, boosting diagnosis capacity and patient satisfaction. This fuels adoption and drives market growth.
Ambulatory urodynamics systems are projected to grow at the fastest CAGR of 7.1% over the forecast period. The development of ambulatory urodynamic equipment has revolutionized patient care by enabling urodynamic testing outside of hospitals and clinics. Portable devices allow patients to continue daily activities, reducing anxiety and discomfort. Advancements in wireless communication, miniaturization, and sensor technology have enhanced the efficiency and utility of these systems, providing comprehensive data on urinary functioning.
North America urodynamic equipment and consumables market held the largest share of 44.6% of the global urodynamic equipment and consumables market in 2023. The majority of healthcare funds in North America are allocated to the treatment and diagnosis of urological conditions. Healthcare facilities in the area are advised to purchase advanced equipment and supplies due to the region's substantial healthcare expenditure and beneficial reimbursement policies for urodynamic testing. The growing emphasis on early disease detection and proactive healthcare contributes to the increased demand for urodynamic testing.
The urodynamic equipment and consumables market in the U.S. dominated the North America urodynamic equipment and consumables market with a share of 77.8% in 2023. The growth is driven by factors such as high healthcare spending, advanced medical infrastructure, and significant investments in diagnosing and treating urological disorders. The rising prevalence of LUTS and conditions such as urinary incontinence and BPH further contributes to market growth. Favorable reimbursement policies and a well-established network of healthcare facilities also support the U.S. market's dominance.
Europe urodynamic equipment and consumables market was identified as a lucrative region in the global urodynamic equipment and consumables market in 2023. The healthcare system in Europe offers a wide range of urological services, such as urodynamic testing and treatment, with extensive coverage. This guarantees that patients can obtain essential diagnostic tests, which in turn increases the need for urodynamic equipment and supplies.
The urodynamic equipment and consumables market in Germany is expected to grow rapidly in the coming years due to the initiatives and funding programs by the German government, healthcare research and development are encouraged, leading to innovation in urodynamic equipment and consumables. This assistance makes it easier to launch new products and increases public awareness.
Asia Pacific urodynamic equipment and consumables market is anticipated to witness significant growth of 5.8% in the global urodynamic equipment and consumables market. The Asia-Pacific region is experiencing increasing healthcare expenditure as economies prosper, driving investment in advanced medical technology, including urodynamic devices. Growing awareness of urological issues among the general population and healthcare professionals is expected to boost the market for urodynamic supplies and equipment. The demand for less invasive surgical procedures is also driving demand for accurate diagnosis, requiring more urodynamic equipment.
The urodynamic equipment and consumables market in China is poised for significant growth driven by the rising prevalence of urological diseases caused by factors such as obesity, decreased physical activity, and genetic factors. These diseases necessitate urodynamic testing and equipment for accurate diagnosis and management, thereby increasing demand for urodynamic equipment and supplies.
Some key companies in the urodynamic equipment and consumables market include Boston Scientific Corporation; Laborie; Verathon, Inc.; and others. Leading players in the urodynamic market are introducing innovative products and services, prioritizing accuracy, efficiency, and patient comfort. Strategic partnerships, mergers, and acquisitions drive market expansion and competitive advantage.
Laborie Medical Technologies is an international company that creates, produces, and sells cutting-edge medical technology and supplies for diagnosing and treating Urinary and Fecal Incontinence, along with other pelvic floor disorders in the Urology, Gynecology, and Colorectal sectors.
Verathon Inc (Verathon), a medical equipment manufacturer, offers a range of imaging and respiratory products, including video laryngoscopes, bronchoscopes, and airway visualization systems, for use in various medical specialties.
The following are the leading companies in the urodynamic equipment and consumables market. These companies collectively hold the largest market share and dictate industry trends.
In June 2024, Boston Scientific Corporation discovered three revolutionary remedies for prevalent health concerns in men, specifically Benign prostatic hyperplasia (BPH), Male stress urinary incontinence (SUI), and Erectile dysfunction (ED).
In March 2024, Laborie Medical Technologies Corp. invested in iO Urology, a startup company that developed CarePath, an FDA-approved at-home uroflow device. CarePath's user-friendly design enabled the device to be shipped directly to patients' residences, featuring built-in cellular connectivity.
Report Attribute |
Details |
Market size value in 2024 |
USD 321.6 million |
Revenue forecast in 2030 |
USD 449.2 million |
Growth rate |
CAGR of 5.7% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Key companies profiled |
Boston Scientific Corporation; Laborie; Verathon, Inc.; Digitimer Ltd; Creo Medical; SRS Medical; Innova Medical Group inc.; MEDKONSULT medical technology |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global urodynamic equipment and consumables market report based on type and region.
Type Outlook (Revenue, USD Million, 2018 - 2030)
Uroflowmetry Equipment
Cystometer
Ambulatory Urodynamics Systems
Electromyographs
Video Urodynamics Systems
Urodynamics Disposables
Urodynamic Catheters
Urodynamic Pumps and Transducer Sets
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."